These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32132675)

  • 1. Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852.
    Koyama N; Shigeno S; Kanamoto A; Tomoda H
    J Antibiot (Tokyo); 2020 Aug; 73(8):581-584. PubMed ID: 32132675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kimidinomycin, a new antibiotic against Mycobacterium avium complex, produced by Streptomyces sp. KKTA-0263.
    Hikima A; Asamizu S; Onaka H; Zhang H; Tomoda H; Koyama N
    J Antibiot (Tokyo); 2022 Feb; 75(2):72-76. PubMed ID: 34949834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex.
    Hosoda K; Koyama N; Kanamoto A; Tomoda H
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30995807
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239.
    Shigeno S; Kadowaki M; Nagai K; Hosoda K; Terahara T; Nishimura T; Hasegawa N; Tomoda H; Ohshiro T
    J Antibiot (Tokyo); 2024 May; 77(5):265-271. PubMed ID: 38531967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A
    J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mavintramycin A is a promising antibiotic for treating
    Hosoda K; Koyama N; Shigeno S; Nishimura T; Hasegawa N; Kanamoto A; Ohshiro T; Tomoda H
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0091723. PubMed ID: 38334410
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections.
    Maesaki S; Kohno S; Koga H; Miyazaki Y; Kaku M
    Chest; 1993 Nov; 104(5):1408-11. PubMed ID: 8222796
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.
    Renvoisé A; Bernard C; Veziris N; Galati E; Jarlier V; Robert J
    J Clin Microbiol; 2014 Dec; 52(12):4439-40. PubMed ID: 25274991
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
    Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
    Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
    Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
    Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.
    Cha SB; Jeon BY; Kim WS; Kim JS; Kim HM; Kwon KW; Cho SN; Shin SJ; Koh WJ
    PLoS One; 2015; 10(9):e0139251. PubMed ID: 26406237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
    Bermudez LE; Kolonoski P; Wu M; Aralar PA; Inderlied CB; Young LS
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1870-4. PubMed ID: 10428905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.